About
Re-myelinating therapies
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (18)
Alexandra Tolia
Independent strategic advisor
Rewind Therapeutics
advisor
Anja Harmeier
Chief Executive Officer
Rewind Therapeutics
executive
Bauke Anninga
Investment Director, M Ventures
Rewind Therapeutics
team_member
Catherine Lubetzki
Professor Emeritus of Neurology at Sorbonne University and former Head of the Department of Neurological Diseases in Salpêtrière Hospital (Paris, France)
Rewind Therapeutics
team_member
Christophe Van Vaeck
Chief Financial Officer
Rewind Therapeutics
executive
Claus Andersson
General Partner, Sunstone Life Science Ventures
Rewind Therapeutics
team_member
Locations (1)
Headquarters
Leuven, Belgium
Map
Loading map...